Controversial research aims to develop more potent H7N9

10/24/2013 | New York Post

Scientists Ron Fouchier and Ab Osterhaus are manipulating the genome of the H7N9 avian influenza virus in an effort to create a strain that is easily transmissible among humans. They say developing such a strain would be a major advancement in learning how to prevent and treat the already deadly influenza virus, which has killed 45 of the 136 people who have been infected. However, opponents think the work is risky. Steven Salzberg, a professor at the Johns Hopkins University School of Medicine, said, "The notion of 'gain of function' research on pathogens is very, very dangerous."

View Full Article in:

New York Post

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA